Protection from renal fibrosis, putative role of TRIB3 gene silencing

Experimental and Molecular Pathology

Volumn 96, Issue 1, 2014, Pages 80-84

  Ding, Wen yuan ^a   Li, Wen bo ^a   Ti, Yun ^a   Bi, Xiu ping ^a   Sun, Hui ^a   Wang, Zhi hao ^a   Zhang, Yun ^a   Zhang, Wei ^a   Zhong, Ming ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

MAPK; Renal fibrosis; SiRNA; TRIB3

Indexed keywords

INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME PHOSPHORYLATION; GENE; GENE ACTIVITY; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; INSULIN RESISTANCE; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; LIPID DIET; MALE; MOLECULAR PATHOLOGY; NONHUMAN; RAT; RENAL PROTECTION; TRIB3 GENE; UPREGULATION;

MAPK; RENAL FIBROSIS; SIRNA; TRIB3;

ANIMALS; CELL CYCLE PROTEINS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROSIS; GENE SILENCING; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; INSULIN RESISTANCE; KIDNEY DISEASES; MALE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; REPRESSOR PROTEINS; RNA, SMALL INTERFERING;

EID: 84891954172     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2013.12.003     Document Type: Article

References (19)

1. Du K., Herzig S., Kulkarni R.N., Montmin M. TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 2003, 300:1574-1577.
2. Eitner F., Floege J. Novel insights into renal fibrosis. Curr. Opin. Nephrol. Hypertens. 2003, 12:227-232.
3. François H., Placier S., Flamant M., Tharaux P.L. Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition. FASEB J. 2004, 18:926-928.
4. Kiss-Toth E., Bagstaff S.M., Sung H.Y., Jozsa V., Dempsey C., Caunt J.C., Oxley K.M., Wyllie D.H., Polgar T., Harte M., O'neill L.A., Qwarnstrom E.E., Dower S.K. Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J. Biol. Chem. 2004, 279:42703-42708.
5. Koo S.H., Satoh H., Herzig S., Lee C.H., Hedrick S., Kulkarni R., Evans R.M., Olefsky J., Montminy M. PGC-1 promotes insulin resistance in liver through PPAR-a-dependent induction of TRB-3. Nat. Med. 2004, 10:530-534.
6. Kim J.A., Montagnani M., Koh K.K., Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006, 113:1888-1904.
7. Kang L., Ayala J.E., Lee-Young R.S., Zhang Z., James F.D., Neufer P.D., Pozzi A., Zutter M.M., Wasserman D.H. Diet-induced muscle insulin resistance is associated with extracellular matrix remodeling and interaction with integrin α2 β1 in mice. Diabetes 2011, 26:416-426.
8. Lu J., Bankovic-Calic N., Ogborn M., Saboorian M.H., Aukema H.M. Detrimental effects of a high fat diet in early renal injury are ameliorated by fish oil in han:sPRD-cy rats. J. Nutr. 2003, 133:180-186.
9. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006, 69:213-217.
10. Morse E., Schroth J., You Y.H., Pizzo D.P., Okada S., Ramachandrarao S., Vallon V., Sharma K., Cunard R. TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1. Am. J. Physiol. Renal Physiol. 2010, 299:965-972.
11. Nishida M., Okumura Y., Sato H., Hamaoka K. Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy. Nephrol. Dial. Transplant. 2008, 23:2520-2524.
12. Prudente S., Hribal M.L., Flex E., Turchi F., Morini E., De Cosmo S., Bacci S., Tassi V., Cardellini M., Lauro R., Sesti G., Dallapiccola B., Trischitta V. The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. Diabetes 2005, 54:2807-2811.
13. Park J.K., Fischer R., Dechend R., Shagdarsuren E., Gapeljuk A., Wellner M., Meiners S., Gratze P., Al-Saadi N., Feldt S., Fiebeler A., Madwed J.B., Schirdewan A., Haller H., Luft F.C., Muller D.N. p38 mitogen-activated protein kinase inhibition ameliorates angiotensin II-induced target organ damage. Hypertension 2007, 49:481-489.
14. Remuzzi G., Bertani T. Pathophysiology of progressive nephropathies. N. Engl. J. Med. 1998, 339:1448-1456.
15. Saka M., Obata K., Ichihara S., Cheng X.W., Kimata H., Noda A., Izawa H., Nagata K., Yokota M. Attenuation of ventricular hypertrophy and fibrosis in rats by pitavastatin: potential role of the RhoA-extracellular signal-regulated kinase-serum response factor signalling pathway. Clin. Exp. Pharmacol. Physiol. 2006, 33:1164-1171.
16. Sánchez-López E., Rodriguez-Vita J., Cartier C., Rupérez M., Esteban V., Carvaja G., Rodrígues-Díez R., Plaza J.J., Egido J., Ruiz-Ortega M. Inhibitory effect of interleukin-1β on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells. Am. J. Physiol. Renal Physiol. 2008, 294:149-160.
17. Taniguchi C.M., Emanuelli B., Kahn C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 2006, 7:85-96.
18. Ti Y., Xie G.L., Wang Z.H., Bi X.L., Ding W.Y., Wang J., Jiang G.H., Bu P.L., Zhang Y., Zhong M., Zhang W. TRB3 gene silencing alleviates diabetic cardiomyopathy in a Type 2 diabetic rat model. Diabetes 2011, 60:2963-2974.
19. Wei Y., Sowers J.R., Nistala R., Gong H., Uptergrove G.M., Clark S.E., Morris E.M., Szary N., Manrique C., Stump C.S. Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J. Biol. Chem. 2006, 281:35137-35146.